On May 16, 2018, HCI hosted a NASA astronaut and a team from the Center for the Advancement of Science in Space to discuss the opportunity of researching cancer in space.
Cancer Research Posts
HCI established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Theresa Werner, MD, was recently honored with a Huntsman Translational Scholar award. She is the medical director of Clinical Trials and treats patients with gynecologic cancers.
Huntsman Cancer Institute Opens Center for HOPE and is Awarded $9.7 Million to Improve Health Among Underserved Populations
Huntsman Cancer Institute (HCI) at the University of Utah (U of U) today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity (HOPE), a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients. The center recently received $9.7 million from the Patient-Centered Outcomes Research Institute (PCORI) to fund a clinical trial researching new and effective approaches to reduce tobacco use.
“Driving Innovative Cancer Science to Patient Care” was the theme of the American Association for Cancer Research (AACR) annual meeting, which took place April 14-18 in Chicago. Huntsman Cancer Institute (HCI) faculty and staff joined almost 22,000 other scientists, physicians, and patient advocates from around the world to share the latest findings in translational, clinical, and prevention-focused cancer research.
HCI established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Robert Andtbacka, MD, was recently honored with a Huntsman Translational Scholar award and will also lead the group for the coming year.
The PathMaker Cancer Research Program is for high school and undergraduate students with backgrounds underrepresented in the biomedical workforce. Under the mentorship of an HCI scientist, PathMaker scholars conduct research and build a foundation for careers in health professions and biomedical research.
The Young Adult Cancer Caregiver study is currently recruiting participants. The study will look at how social media may help or hinder young adults who take care of a cancer patient.
This infographic highlights a few of Huntsman Cancer Institute's accomplishments in 2017.
Advancing discoveries made in the lab to medical treatments that can be used in patient care is complex and time-consuming. Commonly called clinical translation, this process can be thought of much like translating something from one language to another.
Huntsman Cancer Institute began in 1995 with an empty lot and a dream full of promise. Twenty-two years later, HCI opened a major expansion that doubled its research capacity.
Targeted therapy in cancer treatment is often called personalized or precision medicine, according to the National Institutes of Health. Targeted therapies are designed to be more effective and less harmful than other approaches because the drugs are specially designed to meet the individual characteristics of each patient.
Christina Ratcliff enrolled in HCI's Total Cancer Care study, a partnership among patients, health care providers, and researchers to help accelerate cancer research and improve patient care.
Through community partnerships, Huntsman Cancer Institute is reaching adolescent and young adult (AYA) populations where they are – in schools, neighborhoods, and communities – with an educational recipe for a lifetime of healthy living.
Over the years, there have been many landmark discoveries in the effort to eradicate cancer. Progress can only continue with well-trained and passionate researchers and physicians. Huntsman Cancer Institute faculty work with students of all ages to cultivate the next generation of scientists who will carry on this life-saving work.
Remembering to take medication can be a struggle for anyone, but it’s usually a tougher challenge for teens and young adults with cancer. A recent study shows using a smartphone reminder app helps patients in this age group take medication as prescribed.
HCI post-doctoral fellow Andreana Holowatyj, PhD received an award for her work studying colorectal cancer in young adults from the Conquer Cancer Foundation of the American Society of Clinical Oncology.
Huntsman Cancer Institute (HCI) is pleased to announce the appointment of two of our colleagues as holders of prestigious endowed chairs at the University of Utah. Endowed chairs recognize academic distinction, promote excellence, and provide funds for cutting-edge research.
Dr. Martin McMahon and his research group study the genetic mutations that contribute to lung cancer. About 30% of lung cancers can now be treated based on the disease’s specific genetics. McMahon is hopeful that each subset of lung cancer will soon have its own precision treatment.
Kali Dale, a graduate research assistant at HCI, was selected to receive the National Cancer Institute Graduate Diversity Supplement.
Gurkan Mollaoglu, a graduate student in the Oliver Lab, received an F99 NCI Predoctoral to Postdoctoral Fellow Transition Award. This prestigious grant recognizes and supports outstanding graduate students who have demonstrated potential and interest in pursuing careers as independent cancer researchers.